Unihealth Hospitals Limited reported an 82.87% year-on-year increase in net profit to ₹25.83 Cr for the financial year FY26, driven by robust operational performance across its global healthcare verticals. Total income rose 34.61% to ₹137.01 Cr, while EBITDA surged 48.91% to ₹58.82 Cr, reflecting improved operational efficiency. The company's Net Profit Margin expanded by 498 basis points to 18.85%, underscoring its profitability enhancement during the period.

The financial results were disclosed in an investor presentation following an earnings conference call on June 03, 2026. The company operates through a diversified business mix including hospital operations, healthcare consultancy, and pharmaceutical exports. A key strategic highlight was the operational launch of its first multi-specialty hospital in Navi Mumbai, Maharashtra, marking its entry into the Indian domestic market.

Financial Performance

For the financial year FY26, Unihealth Hospitals Limited reported the following consolidated financial results:

Geographic Revenue Breakdown

The African market emerged as the primary revenue source, accounting for 84.13% of total income in FY26. Uganda led the geographic segments with revenue of ₹115.27 Cr, followed by India at ₹24.95 Cr. Other contributing regions included Nigeria, the UAE, Tanzania, and Mauritius. This geographic diversification has supported the company's top-line growth and resilience.

Strategic Developments

UMC Hospitals Navi Mumbai, the first healthcare facility of the UniHealth – UMC Hospitals Group in India, has successfully performed its first robotic total knee replacement surgery. Dr. Akshay Parmar, Managing Director of Unihealth Hospitals Limited – UMC Hospitals Group, emphasized that adopting advanced technologies is essential for elevating standards of care. The group continues to expand its footprint through subsidiaries like UMC Victoria Hospital in Uganda and UMC Zhahir Hospital in Nigeria.

Unihealth Hospitals Limited reported a consolidated net profit of ₹25.83 crore for the financial year ended March 31, 2026, marking an 83% increase from ₹14.13 crore in the previous year. The strong performance was driven by a 35% rise in total income, which reached ₹137.01 crore, and significant expansion across India and East Africa. The Board of Directors approved the audited financial results for the standalone and consolidated entities at its meeting held on May 29, 2026.

The company's growth was supported by strategic capacity additions, including the commissioning of UMC Hospitals in Navi Mumbai and the acquisition of UMC Hospital in Entebbe, Uganda. These initiatives increased the total bed capacity from 200 to 400 beds. The consolidated EBITDA for the year stood at ₹58.82 crore, an increase of 49% year-on-year, with an EBITDA margin of 42.93%.

Financial Performance

The standalone financial results also reflected robust growth, with total income rising 93% to ₹13.23 crore. Net profit for the standalone entity increased by 176% to ₹6.49 crore. The diluted earnings per share (EPS) for the consolidated entity was ₹16.52, compared to ₹9.17 in the previous year.

Strategic Expansion

FY26 was a transformational year for the company, marked by the finalization of a lease for a 200-bedded hospital in Nashik and the first successful IVF twin birth at UMC Victoria Hospital in Uganda. The company's diversified business model combines hospital operations with healthcare consultancy, medical value travel, and pharmaceutical exports. Unihealth now employs over 600 professionals across its integrated healthcare network.

Looking ahead, the company aims to integrate and scale its expanded network, focusing on maximizing utilization and strengthening specialty healthcare services. The management remains confident in sustaining growth momentum driven by increased capacity and rising demand for quality healthcare in emerging markets.